Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

On June 17, Boehringer Ingelheim (BI) and Lilly announced the resubmission to the FDA of the SGLT-2 inhibitor Jardiance (empagliflozin) for the treatment of type 2...
How many different factors can affect blood glucose? See the 22 things that can change your blood sugar in the short-term...
Twitter summary: CDC releases state-by-state obesity data, several states see increases in adult obesity rates – childhood obesity rates level off The Center for Disease...
Twitter summary: FDA approves Dexcom Share for remote monitoring of G4 Platinum CGM; data sent to 5 followers Apple devices Today, the FDA approved Dexcom Share , a...
How can we build healthier cities? What city needs the most help? Please contribute to our reader poll!
On September 27, Taking Control of Your Diabetes (TCOYD) will host its 6 th annual patient conference in Des Moines, Iowa. Founder Steve Edelman and his team have...
What do you know about diabetes education? Our interview with AADE President Joan Bardsley.
Twitter summary: @LillyDiabetes launches Trulicity in the US – first ready-to-use once-weekly GLP-1, available w/savings program for commercially insured On November 10...
On May 7, the results of the SEARCH for Diabetes in Youth study published in JAMA found a 21% increase in type 1 diabetes and 31% rise in type 2 diabetes in children...
Why aren’t there more therapies and devices for pediatric patients? Find out why and what we can do to help.
Twitter summary: Roche launches first-ever BGM with built-in bolus calculator – important advance for MDI patients At the recent AADE conference , this August, Roche...
(S)he said what?!?
On June 11, Glooko and the Joslin Diabetes Center announced the release of their HypoMap software , a cool product that really should be able to identify and help...
What are your diabetes landmines? The small blood sugar mistakes I make again and again and how I'm trying to overcome them.
Twitter summary: Lilly’s new basal #insulin Peglispro superior to Sanofi’s Lantus in A1c reduction, though some potential liver safety and hypo concerns On September 4,...
Twitter summary: diasend system now compatible w/ more devices + fitness trackers - system available for patients free of charge! *UPDATE* On November 12, Diasend...
Looking forward to this year’s American Diabetes Association in our hometown! Plus, how we can improve health and wellness?
Back in February, the FDA proposed an update to the nutrition fact labels for food and drinks , which would be the first major update to these labels in over two decades...
How will a new “biosimilar” insulin compare to Sanofi’s Lantus?
In February, Johnson and Johnson announced that its SGLT-2 inhibitor for type 2 diabetes, Invokana (canagliflozin), will undergo trials as a treatment for diabetic...

Pages